Stay updated on HY209 Gel Phase I Clinical Trial

Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HY209 Gel Phase I Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:49:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a clinical trial for the treatment of atopic dermatitis using the GPCR19 agonist HY209, while retaining a more concise mention of the study's design and location.
    Difference
    32%
    Check dated 2025-04-16T01:43:07.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:14:55.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-03-03T22:17:05.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:39:04.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T06:30:09.000Z thumbnail image

Stay in the know with updates to HY209 Gel Phase I Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.